Sg Americas Securities, LLC Aprea Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 01, 2021	SELL	$3.43 - $5.63 $2.05 Million - $3.37 Million	-598,395 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$4.05 - $5.5 $232,846 - $316,211	-57,493 Reduced 8.77%	598,395 $2.92 Million
Q1 2021 May 13, 2021	BUY	$4.73 - $8.15 $2.99 Million - $5.16 Million	632,678 Added 2725.89%	655,888 $3.35 Million
Q4 2020 Feb 04, 2021	SELL	$4.92 - $30.67 $36,698 - $228,767	-7,459 Reduced 24.32%	23,210 $114,000
Q3 2020 Nov 09, 2020	BUY	$21.66 - $38.86 $664,290 - $1.19 Million	30,669 New	30,669 $738,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$3,290
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.